These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15239649)

  • 1. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
    Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
    J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
    J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-affinity relationships of adenosine A2B receptor ligands.
    Beukers MW; Meurs I; Ijzerman AP
    Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor.
    Lane JR; Klaasse E; Lin J; van Bruchem J; Beukers MW; Ijzerman AP
    Biochem Pharmacol; 2010 Oct; 80(8):1180-9. PubMed ID: 20599769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists.
    Zhu R; Frazier CR; Linden J; Macdonald TL
    Bioorg Med Chem Lett; 2006 May; 16(9):2416-8. PubMed ID: 16487705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
    Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
    Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor.
    Lane JR; Klein Herenbrink C; van Westen GJ; Spoorendonk JA; Hoffmann C; IJzerman AP
    Mol Pharmacol; 2012 Mar; 81(3):475-87. PubMed ID: 22188926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Saponaro G; Baraldi S; Romagnoli R; Moorman AR; Gessi S; Varani K; Borea PA
    Bioorg Med Chem; 2007 Apr; 15(7):2514-27. PubMed ID: 17306548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine is not a direct GHSR agonist--artificial cross-talk between GHSR and adenosine receptor pathways.
    Hermansson NO; Morgan DG; Drmota T; Larsson N
    Acta Physiol (Oxf); 2007 May; 190(1):77-86. PubMed ID: 17428235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
    Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
    Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
    FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.
    de Zwart M; Link R; von Frijtag Drabbe Künzel JK; Cristalli G; Jacobson KA; Townsend-Nicholson A; IJzerman AP
    Nucleosides Nucleotides; 1998 Jun; 17(6):969-85. PubMed ID: 9708319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
    Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
    J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of A2B adenosine receptor antagonists].
    Wei J; Yu WQ; Gao QZ
    Yao Xue Xue Bao; 2008 Mar; 43(3):241-6. PubMed ID: 18630258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
    J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.